GSDs and Hormones Flashcards
Type I GSD
Von Gierke’s Disease
affected enzyme in Type I
Glucose 6-phosphatase
Affected tissue in GSD I
liver
kidney
Clinical features of GSD 1
large quanitites of glycogen are formed and stored in hepatocytes, renal and intestinal mucosa cells
liver and kidneys become enlarged
abnormalities of lipids may lead to xanthoma formation
uric acid is often elevated and may cause clinical gout
galactose, fructose and glycerol are metabolized to lactate
elevated blood lactate levels cause metabolic acidoses
treatment of GSD I
blood loss- oral iron
raised uric acid levels - allopurinol
renal function - hyperuricaemia and pyelonephritis
blood glucose - diazoxide
liver transplantation
hepatocellular carcinoma —–> primary disease
GSD Type II
Pompe’s disease
cause of GSD II
deficiency of lysosomal enzyme alpha-1,4 glucosidase (acid maltase)
leads to accumulation of glycogen in many tissues
Clinical feature of GSD II
clinical spectrum is broad
infantile - accumulation of glycogen in cardiac muscle leads to cardiac failure
accumulation may also occur in the liver- results in hepatomegaly and elevation of hepatic enzymes
glycogen accumulation in muscle and peripheral nerves causes hypotonia and weakness
glycogen deposition in blood vessels may result in intracranial aneurysms
Treatment of GSD II
enzyme replacement therapy (alglucosidase alfa)
Diet therapy - high protein, low carbohydrate
Physiotherapy and occupational therapy
GSD Type III
Cori Disease
Affected enzyme GSD III
Glycogen debranching enzyme
Deposition of abnormal glycogen structure
Affected tissues GSD III
Liver and muscle
Clinical features Type III
about 15% - liver
hypoglycemia
poor growth
hepatomegaly
moderate progressive myopathy
symptoms can regress with age
liver cirrhosis and hepatocellular carcinoma
Treatment of Type III
as with type I
protein supplements for muscle disorder
GSD Type IV
Andersen’s disease